Zeytin Pharma Private Limited - Company Profile

It is a business services private limited company based in Thane, Maharashtra, India, established in 2018.
2018 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Zeytin Pharma Private Limited

Zeytin Pharma Private Limited, a active private limited company, was established on 21 September 2018 in Thane, Maharashtra, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74999MH2018PTC314559. Registered under ROC Roc Mumbai Ii. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Mosin Sattar Khatik (Director), Sabir Ali Usman Ali Sayyed (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A/404, Rehmat Mahel, Near Kausa Market Mumbra, Thane, Maharashtra, 400612.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2018PTC314559

  • Registration Number

    314559

  • Incorporation Date

    21 September 2018

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 46.86%
  • Profit Growth **** 48.33%
  • Ebitda **** 22.76%
  • Net Worth 46.42%
  • Total Assets **** 26.29%
Company report

Zeytin Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Zeytin Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Zeytin Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Mosin Sattar Khatik Director 21 Sep 2018 Current
Sabir Ali Usman Ali Sayyed Director 21 Sep 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Zeytin Pharma.

Zeytin Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 46.86% increase. The company also saw a substantial improvement in profitability, with a 48.33% increase in profit. The company's net worth Soared by an impressive increase of 46.42%.

Zeytin Pharma revenue growth over time
Zeytin Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 46.86%
*******
*******
*******
*******
Revenue from Operations
*******
 46.86%
*******
*******
*******
*******
Total Assets
*******
 26.29%
*******
*******
*******
*******
Profit or Loss
*******
 48.33%
*******
*******
*******
*******
Net Worth
*******
 46.42%
*******
*******
*******
*******
EBITDA
*******
 22.76%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Zeytin Pharma?

Unlock access to Zeytin Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Zeytin Pharma?

Unlock and access historical data on people associated with Zeytin Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Zeytin Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zeytin Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Zeytin Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Zeytin Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Zeytin Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii. was recorded as a recent event.

  • Director Appointment

    Progress on Mosin Sattar Khatik was appointed as a Director was appointed as a Director on 21 Sep 2018 & has been associated with this company since 7 years 5 months . was documented.

  • Director Appointment

    Progress on Sabir Ali Usman Ali Sayyed was appointed as a Director was appointed as a Director on 21 Sep 2018 & has been associated with this company since 7 years 5 months . was documented.

  • Company Incorporation

    The activity Zeytin Pharma Private Limited was registered on 21 Sep 2018 with Roc Mumbai Ii & aged 7 years 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Zeytin Pharma Private Limited?

The CIN of Zeytin Pharma Private Limited is U74999MH2018PTC314559.

Where is Zeytin Pharma Private Limited headquartered?

Zeytin Pharma Private Limited is headquartered at A/404, Rehmat Mahel, Near Kausa Market Mumbra, Thane, Maharashtra, 400612.

When was Zeytin Pharma Private Limited incorporated?

Zeytin Pharma Private Limited was incorporated on 21 September 2018.

Who are the current directors of Zeytin Pharma Private Limited?

The current directors of Zeytin Pharma Private Limited are

What is the primary industry of Zeytin Pharma Private Limited?

The primary industry of Zeytin Pharma Private Limited is Business Services.

Is Zeytin Pharma Private Limited a listed company?

Zeytin Pharma Private Limited is unlisted.

What is the capital structure of Zeytin Pharma Private Limited?

The authorized capital of Zeytin Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available